Skip to main content
. Author manuscript; available in PMC: 2012 Mar 5.
Published in final edited form as: Clin Trials. 2011 Aug;8(4):370–379. doi: 10.1177/1740774511410732

Table 1.

Designs

CRM Usual CRM two-stage design making no use of information
on grades.
CRMG(1,0) CRM two-stage design using information on grades only in
first stage.
CRMG(1,1) CRM two-stage design using grades in both stages. For the
second stage, the association parameter between intermedi-
ary toxicities and DLTs is known.
CRMG(1,2) CRM two-stage design using grades in both stages. For the
second stage, the association parameter between interme-
diary toxicities and DLTs is estimated by maximizing the
appropriate likelihood.